It can be hard to sate investors’ appetites, but if there’s two companies who should know how to do it, it’s these two.

US pharma major Eli Lilly today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

For years, obesity was often seen as a result of poor lifestyle choices. However, experts now suggest that biological factors ...

The former Top Gear host said he had to 'do everything in my power to not die' so that he can spend as much time possible with his 'hilarious' granddaughters..

Wonder drugs’ like Ozempic, hailed by celebrities and some medics as a cure for an ever-mounting list of conditions, most notably obesity and diabetes, have started to appear in darker headlines ...

If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

A damaging trial failure in December wiped 70% off the share price of BioAge Labs, a US biopharma developing therapeutic ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

SLOWLY lifting her head off her sweat-drenched pillow, Aisleyne Horgan-Wallace vomits into the sick bucket next to her bed. ...

Vizient released its new Spend Management Outlook representing a comprehensive analysis of emerging trends and pricing dynamics affecting healthcare.

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...